The FDA has announced that it is suggesting a change from the time-based deferrals for blood donation to an individual risk assessment system. The new system will assess blood donation eligibility using gender-inclusive, individual risk-based questions which should reduce the risk of transfusion-transmitted HIV. This system is similar to the systems used in the UK and Canada.
FDA suggests individual risk assessments for blood donations to secure US blood supply
